key: cord-0942378-ake0ki6r
authors: Golden, Nyoman; Niryana, Wayan; Awyono, Steven; Eka Mardhika, Putu; Bhuwana Putra, Made; Stefanus Biondi, Made
title: Transcranial approach as surgical treatment for giant pituitary adenoma during COVID 19 pandemic – What can we learn?: A case report
date: 2021-02-25
journal: Interdiscip Neurosurg
DOI: 10.1016/j.inat.2021.101153
sha: 8f02d9ec21138c6f2709e2c7bcb42deb2a112f63
doc_id: 942378
cord_uid: ake0ki6r

INTRODUCTION: In the COVID 19 pandemic, pituitary surgery is one of challenging surgical treatment, especially the involving transsphenoid approach. It was reported that the aerosolisation and mucosal involvement increase the risk of viral transmission during operation. Therefore, transcranial is a safer surgical approach during COVID-19 pandemic. This study aimed to reported transcranial approach to treat giant pituitary adenoma with aggressive visual disturbance which require urgent surgical management. Case presentation: We reported a 21-year old male, who required urgent surgery because of progressive visual disturbance due to giant pituitary adenoma. On brain MRI with contrast, it was revealed an extraaxial tumor extending anteriorly over plannum sphenoidal with the greatest diameter was 5.34 cm. Transcranial approach was chosen to resect the tumor. Near total removal of the tumor was achieved without damaging vital neurovascular structure. The visual acuity was improved and no significant postoperative complication. Pathology examination revealed pituitary adenoma. CONCLUSION: Transcranial surgery for pituitary adenoma is still an armamentarium in neurosurgical practice, especially in the COVID 19 pandemic to provide safer surgical approach.

1 anterior cerebral artery {ACA}), and nerves (optic nerve, chiasm, pituitary stalk). During 2 surgery, we achieve near-total removal and preserve all of the vital structures. All 3 neurovascular structures, including the optic nerve, chiasm, stalk, ICA and ACA were well 4 exposed and preserved ( Figure 2 ). After the removal, the patient showed increasing urine 5 output (up to 4400 cc per 24 hours) and increasing serum natrium (149 mmol/L), which was 6 diagnosed as diabetes insipidus. The patient was treated with vasopressin 5IU TID, and 7 within one week the urine output and serum natrium were back to normal limit (from 149 8 mmol/L to 137 mmol/L). One week following surgery, the patient showed significant visual 9 improvement with 1/60 for the left eye and 1/300 for the right eye. There were no other A giant pituitary adenoma is defined as adenoma with the largest diameter > 4 cm. [ [18] The surgical approach can be transsphenoidal, which can 20 be performed microscopically or endoscopically, and transcranial approach. [15] 21 Transsphenoidal endoscopic procedure is more commonly practiced and recommended for 22 pituitary adenoma for it is viewed as a safer and more effective approach with lesser 23 complication. [11] The disadvantage of transsphenoidal approach is due to deep and narrow 24 working space. [4, 19] The transcranial approach is usually used in a more complicated case 25 with lateral or anterior extension of the tumor because it can provide more radical resection, 26 which is one of the suggested reason as to why this approach is associated with more Abstract 50 1 Introduction: In the COVID 19 pandemic, pituitary surgery is one of challenging surgical 2 treatment, especially the involving transsphenoid approach. It was reported that the 3 aerosolisation and mucosal involvement increase the risk of viral transmission during 4 operation. Therefore, transcranial is a safer surgical approach during COVID-19 pandemic. 5 This study aimed to reported transcranial approach to treat giant pituitary adenoma with 6 aggressive visual disturbance which require urgent surgical management. 7 Case presentation: We reported a 21-year old male, who required urgent surgery because of 8 progressive visual disturbance due to giant pituitary adenoma. On brain MRI with contrast, it 9 was revealed an extraaxial tumor extending anteriorly over plannum sphenoidal with the 10 greatest diameter was 5.34 cm. Transcranial approach was chosen to resect the tumor. Near 11 total removal of the tumor was achieved without damaging vital neurovascular structure. The 12 visual acuity was improved and no significant postoperative complication. Pathology 13 examination revealed pituitary adenoma. 14 Conclusion: Transcranial surgery for pituitary adenoma is still an armamentarium in 15 neurosurgical practice, especially in the COVID 19 pandemic to provide safer surgical 16 approach. 35 Surgical management for a patient with intracranial tumors during this pandemic era had 36 been a significant concern.

[5] Patients with skull base lesions often require an endonasal 37 approach via transnasal, paranasal sinus, or mastoid. [5] In this era, the development of 38 endoscopic surgery becomes widely used for many surgeries especially for midline skull base 39 lesions such as pituitary adenoma. [6] [7] [8] [9] Endoscopic surgery will provide a panoramic, close-40 up, multi-angled view with excellent illumination and magnification, permitting complete 41 excision of the tumor with preservation of normal pituitary. [10, 11] However, this approach 42 involves the nasal mucosa and has a risk of aerosol generation for virus spreading.

[12] Zhu et 1 diagnosed as diabetes insipidus. The patient was treated with vasopressin 5IU TID, and 2 within one week the urine output and serum natrium were back to normal limit (from 149

3 mmol/L to 137 mmol/L). One week following surgery, the patient showed significant visual 4 improvement with 1/60 for the left eye and 1/300 for the right eye. There were no other 5 significant postoperative complications observed. Pathology examination revealed an oval 6 cell with granulated eosinophilic cytoplasm, an ovoid nucleus with granular chromatin, which 7 concluded as adenoma (Figure 3 ). Postoperative MRI taken three months following surgery 8 showed a small residual tumor (Figure 1 ). The patient has been informed regarding the use of 9 their information in making this case report. 26 In our opinion, in urgent cases, especially with COVID 19 testing limitation, transcranial 27 surgery should be considered to rescue the vision. With meticulous technique and gentle 28 brain tissue manipulation, transcranial surgery is still safe and provides good surgical 29 outcomes.

[32] Regarding the extent of resection, Nishioka et al. concluded that regardless of 30 surgical approach, factors that limit adequate resection were a massive intracranial extension, 31 irregular configuration, and marked cavernous sinus invasion. [33] The lateral extension of

approach developed COVID-19 one week after the surgery, and later on, 14 of their staff 3 were confirmed for SARS-CoV-2.[13] During pandemic COVID-19, pituitary tumors with an

This is a case report of pituitary adenoma and we have the consent from the patient to 10 include any information of his condition in this article

On the first week of March 2020, 13 he experienced progressive visual acuity declining. The ophthalmologist reported his visual 14 acuities were light perception and 1/300 on the right and left eyes, respectively. Other 15 physical examinations did not show any sign of hormonal disturbance, such as a sign of 16 Cushing syndrome, acromegaly, or palpitation

We opt to approach the tumor from the right side because 26 the visual symptoms are much worse on the right eye. Pterional craniotomy on the right side 27 was performed with an additional bone drill on the sphenoid bone to minimize brain 28 retraction. Subarachnoid dissection was performed to drain the cerebrospinal fluid. The tumor 29 was identified surrounding the brain tissue, blood vessels (internal carotid artery {ICA} and 30 anterior cerebral artery {ACA}), and nerves (optic nerve, chiasm, pituitary stalk)

A giant pituitary adenoma is defined as adenoma with the largest diameter > 4 cm

defined this entity as pituitary tumors with an extension more

In this case, the tumor's greatest diameter was 5.34 cm; so, based on Hardy classification, this 9 tumor was classified as giant pituitary adenoma

The clinical presentation of giant pituitary adenoma could be the mass effect, hipopituitary, 11 or hypersecretion of the hormone.[1] The mass effect

13 and cranial nerve palsy, mainly third, fourth, and sixth nerve.[1] In this case, the visual 14 disturbance was the main problem of the patient. Based on the literature, pituitary tumor with 15 suprasellar and anterior extension are the most common cause of visual impairment

The goals of pituitary pituitary function.[18] The surgical approach can be transsphenoidal, which can 20 be performed microscopically or endoscopically, and transcranial approach

reported in their study that they achieved gross-total removal in 44%, near-30 total removal in 47%, and subtotal resection in 9% of patients undergoing endoscopic 31 endonasal resection of giant pituitary adenoma.[21] Leung et al. combined transcranial and 32 transsphenoidal approaches to resect giant pituitary adenoma

Resection (GTR) in 41.7% and Subtotal Resection (STR) in 58.3% of patients

Near Total Resection (NTR) in 9 %, and 1 subtotal resection in 36% of giant pituitary adenoma patients using combined transcranial and 2 transsphenoidal approach.[23] However, Kuga et al. reported only near-total and subtotal 3 removal using a combined endoscopic endonasal and transcranial approach to resect giant 4 pituitary tumors

26] However, it is used in general practice when the transsphenoidal approach 10 fails to remove the desired result. Therefore, there is a continuation of using transcranial 11 surgery for pituitary adenoma, and neurosurgeons should maintain their expertise with this 12 approach

Particular attention should be concerned, particularly for procedures performed involving the 16 nasal mucosa, such as a transsphenoidal approach for pituitary adenoma, considering the 17 tremendous level of viral shedding.[12] It is not the endoscopic procedure is risky, but the 18 nasal and pharyngeal areas are hazardous because they may act as reservoirs with a high viral 19 load.[12] Therefore, all endoscopic, microscopic, and open surgical procedures involving 20 nasal or paranasal sinus and pharyngeal regions must be considered at risk

Transcranial surgery for pituitary adenomas

Clinical 4 outcomes after endoscopic endonasal resection of giant pituitary adenomas

Combined simultaneous 7 transcranial and transsphenoidal resection of large-to-giant pituitary adenomas

Simultaneous above and below approach to giant pituitary adenomas: surgical strategies 11 and long-term follow-up

Endoscopic endonasal approach 14 combined with a simultaneous transcranial approach for giant pituitary tumors

Endoscopic skull 17 base surgery: a comprehensive comparison with open transcranial approaches

Endoscopic 23 endonasal compared with microscopic transsphenoidal and open transcranial resection of 24 giant pituitary adenomas

Safety 27 recommendations for evaluation and surgery of the head and neck during the COVID-19 28 pandemic

Endocrinology in the time of 31 COVID-19: management of Cushing's syndrome

Transcranial 34 versus endoscopic transsphenoidal approaches in management of recurrent giant pituitary 35 adenomas, Maced

The COVID-19 pandemic: consideration for brain infection

Surgical treatment of aggressive pituitary adenomas and 40 pituitary carcinomas

43 Inherent tumor characteristics that limit effective and safe resection of giant 44 nonfunctioning pituitary adenomas

How to deal with giant pituitary adenomas: 47 transsphenoidal or transcranial, simultaneous or two-staged?

1 In our case, a near-total resection of the tumor was done, the visual disturbance is 2 significantly improved without significant clinical complication. When transcranial 3 approaches are used, it must be tailored according to the direction of tumor extension, the 4 goal of surgery, the skill of the surgical team, and surgeon preference. The traditional 5 pterional approach provides a clear surgical view and allows almost complete tumor removal 6 with good preservation of neurovascular structures. Even though this approach is not 7 preferred for the surgery on the sellar region, our consideration to select transcranial surgery 8 is due to pandemic and the tumor extension over planum sphenoidal, in which, in our 9 opinion, it needs combined approaches. Limitation of this study is unable to performing RT-10 PCR to detect COVID-19 due to limitiation in our hospital.

Transcranial surgery for pituitary adenoma is still an armamentarium in neurosurgical